| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $1.12B | +0.2% |
| Cost of Revenue | $387.9M | +4.6% |
| Gross Profit | $735.2M | -2.0% |
| R&D Expense | $78.8M | -7.5% |
| SG&A Expense | $365.1M | +7.0% |
| Operating Income | $166.8M | -24.7% |
| Pre-tax Income | $44.2M | -58.2% |
| Income Tax | -$34.1M | -196.6% |
| Net Income | $78.3M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $267.5M | -18.1% |
| Accounts Receivable | $193.0M | +1055.7% |
| Inventory | $171.5M | +12.8% |
| Current Assets | $761.0M | +1.6% |
| Total Assets | $1.29B | +5.8% |
| Current Liabilities | $374.0M | +5.8% |
| Long-term Debt | $1.57B | -1.2% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $35.7M | -47.3% |
| Capital Expenditures | $15.8M | -40.4% |
| Investing Cash Flow | -$15.8M | +40.4% |
| Financing Cash Flow | -$73.4M | -50.7% |
| Free Cash Flow | $19.9M | -51.7% |
| +11.2% |
| EPS (Basic) | $1.36 | +10.6% |
| EPS (Diluted) | $1.34 | +9.8% |
| Stockholders' Equity |
| -$738.3M |
| +10.1% |